ARTICLE | Company News
Bioxel, Cell Therapeutics deal
February 23, 2004 8:00 AM UTC
BIP said CTIC will purchase at least C$1.2 million (US$912,000) of BIP's cGMP paclitaxel. The paclitaxel will be used to produce CTIC's Xyotax polyglutamate polymer formulation of paclitaxel, which i...